相关实验视频

Updated: Jun 26, 2025

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

开发基于TRIB3的疗法作为治疗视网膜退行性疾病的基因独立方法

Trong Thuan Ung¹, Christopher R Starr¹, Assylbek Zhylkibayev¹

¹Department of Optometry and Vision Science, University of Alabama at Birmingham, Birmingham, AL 35233, USA.

International journal of molecular sciences

|May 11, 2024

概括

这项研究表明,针对TRIB3的新基因独立疗法可以改善视力,并减缓遗传性视网膜退化 (RD) 中的细胞损失. 该方法使用药物向TRIB3相互作用体,为治疗RD中常见的信号通路提供了希望.

科学领域:

眼科医生眼科眼科
遗传学遗传学是一个
分子生物学分子生物学

背景情况:

遗传性视网膜退化 (RD) 涉及多种遗传原因,但具有共同的途径:慢性激活未折叠蛋白反应 (UPR).
在PERK-UPR路径中,TRIB3起着关键的调解作用,通过抑制AKT → mTOR轴来影响代谢信号传递.
现有的RD治疗方法通常是基因特异性的,这突显了对基因独立治疗策略的需求.

研究的目的:

开发和验证一种基因独立的治疗策略,针对RD的小鼠模型中的UPR介质TRIB3.
通过药理性抑制EGFR-TRIB3和透细胞向TRIB3 → AKT的向TRIB3互动组的有效性.

主要方法:

利用了遗传性视网膜退行症的rd10和P23H RHO小鼠模型.
在p15 rd10小鼠中通过腹腔内注射给药阿法替尼 (EGFR-TRIB3抑制剂).
通过眼内注射向P15 P23H RHO小鼠输送细胞透 (TRIB3 → AKT向)

主要成果:

阿法替尼和细胞透治疗都成功地准了TRIB3互动分子.
电磁录像 (ERG) 记录显示,在接受治疗的小鼠中,斯科托普A和B波幅有所改善.
阿法替尼治疗增强了光学ERG幅度和延迟了光受体细胞损失;rd10视网膜显示PDE6β和RHO染色增加和PDE活性升高.

结论:

针对TRIB3的基因独立治疗方法可用于治疗遗传性视网膜退化.
在不同的 RD 模型中,对 TRIB3 互动组的药理学向有效地延迟了视网膜功能障碍和光受体细胞损失.
这种基于TRIB3的策略为解决各种形式的RD中常见的信号缺陷提供了一个有希望的途径.

关键词:

在Tribe3中,Tribe3是指Tribe3,Tribe3是指Tribe3.亚法提尼布 (Afatinib) 是一种细胞透的酸.视网膜退化视网膜退化不折叠的蛋白质反应反应

更多相关视频

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Published on: February 4, 2021

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.